- Trials with a EudraCT protocol (133)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (52)
133 result(s) found for: PPI.
Displaying page 1 of 7.
EudraCT Number: 2018-000283-28 | Sponsor Protocol Number: 64821 | Start Date*: 2018-09-05 |
Sponsor Name: | ||
Full Title: Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia: a pilot study | ||
Medical condition: Angiogenic markers in preeclampsia | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001383-10 | Sponsor Protocol Number: 57340 | Start Date*: 2016-07-04 |
Sponsor Name:Rijnstate ziekenhuis | ||
Full Title: Evaluating the effect of short term withdrawal of PPI's in patients for reducing stomach wall uptake with 99mTc Sestamibi for myocardial perfusion imaging | ||
Medical condition: The goal is to acquire knowledge about the impact of the withdrawal of PPI’s, so as to minimize disturbance of the stomach wall in myocardial perfusion imaging. The associated main question is ther... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000789-35 | Sponsor Protocol Number: HPTM06/J/05 | Start Date*: 2006-10-06 |
Sponsor Name:INFAI GmbH | ||
Full Title: Two-way Crossover Comparison of the Sensitivity and Specificity of the Modified Helicobacter Test INFAI Using New Test Meal vs. Standard 13C-Urea Breath Test in Helicobacter Pylori Positive and Neg... | ||
Medical condition: Diagnosis of Helicobacter pylori infection for patients taking proton pump inhibitors (PPI) without interuption of medication two weeks prior to test. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000059-17 | Sponsor Protocol Number: RVK28353 | Start Date*: 2011-02-22 | |||||||||||
Sponsor Name:Koege Hospital | |||||||||||||
Full Title: The clinical significance of acid rebound: Symptoms of reflux after 8 weeks of PPI treatment in patients with functional dyspepsia. | |||||||||||||
Medical condition: "Acid-Rebound Hypersecretion" and "Functional dyspepsia" | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008010-39 | Sponsor Protocol Number: HPTM11/J/08 | Start Date*: 2009-04-23 |
Sponsor Name:INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH | ||
Full Title: The Sensivity and Specificity of the Modified Helicobacter Test INFAI Using New Test Meal with 13C-Urea Breath Test in Helicobacter Pylori Positive and Negative Patients with Dyspepsia Taking Proto... | ||
Medical condition: Diagnosis of Helicobacter pylori infection for patients taking proton pump inhibitors (PPI) with one day break of medication instead of two weeks prior to the test | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001635-29 | Sponsor Protocol Number: | Start Date*: 2006-02-07 |
Sponsor Name:Daniel Schmidt | ||
Full Title: Kontrollerad utsättning av långvarig behandling med protonpumpshämmare. | ||
Medical condition: Patienter med till synes obefogad kontinuerlig medicinering med protonpumpshämmare. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004239-78 | Sponsor Protocol Number: | Start Date*: 2005-07-01 |
Sponsor Name:Göteborgs Universitet, Institutionen för Invärtesmedicin | ||
Full Title: Förekomst av syrarelaterade besvär efter utsättning av protonpumpshämmare hos friska frivilliga. | ||
Medical condition: Studien skall göras på friska försökspersoner | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001169-21 | Sponsor Protocol Number: S55731 | Start Date*: 2015-04-14 |
Sponsor Name:Catholic University Leuven | ||
Full Title: Acid pocket: Determination of position and aspiration | ||
Medical condition: Gastro-oesophageal reflux disease Healthy volunteers and patients with reflux disease who respond to PPI therapy and who partially respond to PPI therapy will be studied It is known, that after the... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001314-25 | Sponsor Protocol Number: KIANANDR140701 | Start Date*: 2015-03-10 |
Sponsor Name:Karolinska Institutet | ||
Full Title: The effect of on demand versus continuous use of proton pump inhibitors on reflux symptoms, quality of life and self-rated health in patients with gastro-oesophageal reflux disease | ||
Medical condition: Gastrooesophageal reflux disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2009-017351-96 | Sponsor Protocol Number: baclofen2009 | Start Date*: 2009-12-23 |
Sponsor Name:UZleuven | ||
Full Title: A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI response | ||
Medical condition: Gastroesophageal reflux disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000603-32 | Sponsor Protocol Number: NL3364409612 | Start Date*: 2012-08-27 |
Sponsor Name:Annadalstichting | ||
Full Title: Proton pump inhibitors in the prevention of iron reaccumulation in patients with hereditary hemochromatosis | ||
Medical condition: Hereditary hemochromatosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003319-91 | Sponsor Protocol Number: CX842A2201 | Start Date*: 2021-02-08 | |||||||||||
Sponsor Name:Cinclus Pharma AG | |||||||||||||
Full Title: A randomized double-blind, double dummy, active comparator-controlled dose finding study in patients with reflux esophagitis Los Angeles grade C or D, and patients with at least partial symptom res... | |||||||||||||
Medical condition: reflux esophagitis Los Angeles grade C or D and patients with grades A or B who partially responded to PPI patients with grades A or B who partially responded to PPI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004355-23 | Sponsor Protocol Number: PPI-microbiome-FD | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in Functional Dyspepsia patients | ||
Medical condition: Functional Dyspepsia (FD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005340-39 | Sponsor Protocol Number: S64807 | Start Date*: 2021-02-01 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: Duodenal neuro-immune interactions and effects of proton pump inhibitors in functional dyspepsia | ||
Medical condition: Functional Dyspepsia (FD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003541-16 | Sponsor Protocol Number: D9120C00011 | Start Date*: 2006-11-07 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, multi-centre, phase IIA study to assess the effect on GERD symptoms, pharmacokinetics, safety and tolerability of four weeks treatment with AZD3355 6... | |||||||||||||
Medical condition: Gastroesophageal Reflux Disease (GERD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NO (Completed) NL (Completed) DE (Completed) HU (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004503-31 | Sponsor Protocol Number: PSC-DSGERDAP16 | Start Date*: 2017-03-14 | |||||||||||
Sponsor Name:SOFAR S.P.A. | |||||||||||||
Full Title: Evaluation of the effect of Gerdoff administered in combination to a treatment with protonic pump inhibitors vs the only treatment with protonic pump inhibitors, administered for 6 weeks, on higher... | |||||||||||||
Medical condition: Gastroesophageal reflux disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000334-30 | Sponsor Protocol Number: INT27/14 | Start Date*: 2014-09-17 | |||||||||||
Sponsor Name:Fondazione IRCCS ''IStituto Nazionale dei Tumori'' | |||||||||||||
Full Title: Immunomodulatory effect of esomeprazole antitumoral and high-dose under neoadjuvant and adjuvant in patients with melanoma in stage III. Randomized pilot study treatment vs control | |||||||||||||
Medical condition: metastatic melanoma BLS+ and BRAF wt | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004175-31 | Sponsor Protocol Number: Prucalopride2017 | Start Date*: 2018-04-09 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: A placebo-controlled trial with prucalopride for the treatment of typical reflux symptoms in patients with gastro-esophageal reflux disease with incomplete proton pump inhibitor response | ||
Medical condition: refractory gastro-esophageal reflux disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004248-39 | Sponsor Protocol Number: PPI-microbiome | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in healthy volunteers | ||
Medical condition: We will assess the effect of Proton Pump Inhibitors (PPI) on the duodenal, oral and fecal microbiota composition in healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004470-25 | Sponsor Protocol Number: GA1214 | Start Date*: 2013-01-08 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A multicentre, randomised, double-blind, two arm, parallel group, pilot study to assess the effect of Gaviscon® Double Action Mint as add-on therapy in GORD patients with inadequate response to onc... | ||
Medical condition: Patients with Gastro Oesophageal Reflux Disease (GORD) with inadequate response to PPI treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
